Massachusetts General HospitalIdentification and correction of T cell defects in patients with chronic lymphocytic leukemia and impact on T cell therapy....more
Fred Hutchinson Cancer Research Center New approaches to Haploidentical Hemopoietic Cell Transplant...more
University of Pennsylvania Medical Center Activation of Signal Transduction Pathways in Leukemia...more
Washington University, St. Louis Dynamic Changes in MDS Clonal Architecture During Treatment with Hypomethylating Agents...more
Assistant Professor Molecular Rationale for WNT Inhibitor Therapy in B-Cell LymphomaUNC Lineberger...more
University of California, San Francisco The Development of Murine Models of Recurring Myeloid Leukemia-Associated Chromosomal Deficiencies...more
Memorial Sloan-Kettering Cancer Center The Role of ASXL1 mutations in leukemia patients...more
Dartmouth Medical School Targeting MLL-Cofactor Interaction to Selectively Block Mixed Lineage Leukemia...more
Johns Hopkins, Sidney Kimmel Comprehensive Cancer Center Investigating promoter hypermethylation in the biology of MLL-rearranged leukemia, and as a novel...more
MD Anderson Cancer Center Fish oil (n-3 fatty acids) and non-Hodgkin lymphoma...more
Regents of the University of Michigan Nras signaling in hematopoietic stem cells and leukemic stem cells...more
St. Jude Children's Research Hospital Systematic, High-Throughput Developmental Therapeutics in High-Risk ALL...more
Sylvester Comprehensive Cancer CenterUniversity of MiamiTargeting NEDD8 protein conjugation: a novel therapeutic strategy for acute lymphoblastic leukemia (ALL)....more
Memorial Sloan-Kettering Cancer Center Genomic characterizations of myeloproliferative neoplasms...more
Assistant Professor University of Utah Investigating the collaboration between microRNAs and oncogenes in leukemia...more
p class="projectTitle">University of Pennsylvania School of Medicine Novel approaches to enhancing the therapeutic index of chimeric antigen receptor T cell...more
Albert Einstein College of MedicineTargeting NOXA methylation to overcome Bortezomib resistance in MCL...more
Yale School of Medicine Cell Death Regulation by Pro-Apoptotic BOK in Multiple Myeloma...more
Gabrielle’s Angel Foundation for Cancer Research
420 Lexington Avenue, Suite 226,
New York, NY 10170 (646) 861-2033,
info@gabriellesangels.org
Copyright © 2008 - 2017 Gabrielle's Angel Foundation
For Cancer Research.
All rights reserved. Privacy Policy
Gabrielle's Angel Foundation is a 501(c)(3) tax-exempt organization; Federal Tax ID Number 13-3916689.
2015 Annual Report (PDF)
Form 990 (PDF)
